methoxyhydroxyphenylglycol has been researched along with olanzapine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anguiano, JB; Arrúe, A; Basterreche, N; Dávila, R; Zamalloa, MI; Zumárraga, M | 1 |
| Hori, H; Ida, Y; Ikenouchi, A; Mitoma, M; Nakamura, J; Yamada, Y; Yoshimura, R | 1 |
| Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Amianto, F; Brambilla, F; Dalle Grave, R; Fassino, S | 1 |
2 trial(s) available for methoxyhydroxyphenylglycol and olanzapine
| Article | Year |
|---|---|
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Catecholamines; Cytokines; Female; Homovanillic Acid; Humans; Interleukin-2; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.
Topics: Administration, Oral; Adult; Analysis of Variance; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Bulimia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Olanzapine; Paroxetine; Psychotherapy, Brief; Serotonin Plasma Membrane Transport Proteins; Treatment Failure | 2014 |
2 other study(ies) available for methoxyhydroxyphenylglycol and olanzapine
| Article | Year |
|---|---|
Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biogenic Monoamines; Bipolar Disorder; Catechol O-Methyltransferase; Drug Therapy, Combination; Female; Gene Expression; Genetic Predisposition to Disease; Genotype; Homovanillic Acid; Humans; Lithium Carbonate; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Polymorphism, Genetic; Prevalence; Psychotic Disorders; Severity of Illness Index; Treatment Outcome | 2006 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |